Cephalon Wants FCA Off-Label Marketing Claims Axed
Pharmaceutical company Cephalon Inc. urged a Pennsylvania federal judge on Tuesday to nix a pair of whistleblower suits accusing it of spurring false reimbursement claims to the government through a scheme...To view the full article, register now.
Already a subscriber? Click here to view full article